Content unavailable

Sorry, this content is only available to users that the PSA have verified as healthcare professionals. To learn more, talk to a PSA membership...

Pharmacists and Australia’s COVID-19 vaccination policy

Pharmacies are likely to play a role in COVID-19 vaccination, and people at  increased risk of exposure, including health and aged care workers, will be among the first to receive a vaccine.

How should pharmacists report incidents?

All incidents should be reported, no matter how minor. Here’s how pharmacists can best approach this process.

A new way to discuss inhaler technique

By distinguishing between the two different types of inspiratory flow rates, this new label could help to improve inhaler technique.

First vaccine appointments for 5–11 years run smoothly, amid cancellations

Community pharmacists were some of the first to vaccinate children aged 5–11 against COVID-19 this week.

Five practice pointers for dispensing Paxlovid

Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.